Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer

Cancer Treat Rep. 1987 Sep;71(9):859-60.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / adverse effects
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Antimetabolites, Antineoplastic
  • 5,6-dihydro-5-azacytidine
  • Azacitidine